[Asia Economy Reporter Lee Seon-ae] Hanmi Science announced on the 2nd that at the board meeting on the 1st, it resolved to complete the merger with its affiliate Hanmi Healthcare and posted the notice on its website. Following this merger, the capital increased from KRW 34,311,840,000 to KRW 41,144,070,000. No new shares will be issued due to this merger. Below are the major disclosures released in the afternoon of the same day.


▲ Dongwon F&B = Q3 consolidated operating profit of KRW 45,132,000,000, down 8.01% compared to the same period last year


▲ Life Semantics = Signed an 800 million KRW contract with Funnet to develop and build a Fun Village platform healthcare service, which accounts for 17.26% of recent sales


▲ SKC = Lent KRW 20 billion to SKC Mirae Materials, a subsidiary scheduled for consolidation


▲ Hanwha Systems = Signed a targeting device supply contract worth KRW 159,937,000,000 with the Defense Acquisition Program Administration, amounting to 7.65% of last year’s sales


▲ Daewoo Construction = Won the contract for the Cheongju Sajik 1 District housing redevelopment project, with a contract amount of KRW 277,022,770,000, representing 3.19% of 2021 sales


▲ CE Lab = Signed a contract worth KRW 2.4 billion with BNI&C to expand DGX POD clusters, contract amounting to KRW 2,439,000,000, which is 42.21% of 2021 sales


▲ UCI = Completed capital reduction at a ratio of 87.5%


▲ Dongwon Systems = Q3 consolidated operating profit of KRW 25,014,000,000, down 7.98% compared to the same period last year


▲ Doosan = Q3 consolidated operating profit of KRW 340.6 billion, up 42.7% compared to the same period last year


▲ SK IE Technology = Q3 consolidated operating loss of KRW 22,010,000,000, turning to a deficit compared to the same period last year


▲ Hankook Tire & Technology = Q3 consolidated operating profit of KRW 192,426,000,000, up 6.4% compared to the same period last year


▲ Daesung Holdings = Decided to dispose of 100,000 shares of Seoul City Gas for KRW 30.1 billion, disposal amount representing 5.04% of last year’s consolidated equity



▲ Plazmap = Signed a supply contract worth KRW 89.5 billion with US medical device supplier Qumed, focusing on the North American dental market, amounting to 1409.53% of recent sales


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing